BACIL PHARMA LTD.

BACPHAR

Small Cap | Pharmaceuticals
37.04
-1.05 (-2.75%)

Stock price as on 06 Feb 2026 at 15:27 PM

Bacil pharma ltd. share price update

As of the latest trading session, Bacil Pharma Ltd. share price is currently at ₹37.04, which is down by ₹-1.05 from its previous closing. Today the s...

Bacil Pharma Ltd. stock performance

Today’s low

₹36.9

Today’s high

₹39.5

₹37.04

52 week low

₹26.69

52 week high

₹47.9

₹37.04
Open
₹37.71
Previous close
₹38.10
Share volume
2,330
Total traded value (Lakh)
₹0.89
Upper circuit
₹41.91
Lower circuit
₹34.29

Bacil Pharma Ltd. fundamentals

Market cap (Cr)
₹53.10
P/E ratio (TTM)
84.16
Book value per share
₹18.62
Beta
-0.01
Return on equity
-0.98%
Earnings per share (TTM)
₹0.44
Dividend yield
0%
Net profit/quarter (Cr)
₹0.01

Bacil Pharma Ltd. financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

-

Operating expense

₹0.04

Net income

₹0.01

Net profit margin

-

Earning per share

₹0.01

EBITDA

₹0.02

Effective tax rate

-

Particulars

Jun 25 (₹ value in crores)

Revenue

-

Operating expense

₹0.11

Net income

₹0.67

Net profit margin

-

Earning per share

₹0.48

EBITDA

₹0.89

Effective tax rate

24.71%

Particulars

Mar 25 (₹ value in crores)

Revenue

-

Operating expense

₹0.07

Net income

₹0.02

Net profit margin

-

Earning per share

₹0.03

EBITDA

₹0.02

Effective tax rate

-

Particulars

Dec 24 (₹ value in crores)

Revenue

-

Operating expense

₹0.06

Net income

-₹0.06

Net profit margin

-

Earning per share

-₹0.10

EBITDA

-₹0.06

Effective tax rate

-

Particulars

Sep 24 (₹ value in crores)

Revenue

-

Operating expense

₹0.07

Net income

₹0.48

Net profit margin

-

Earning per share

₹0.82

EBITDA

₹0.49

Effective tax rate

-

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

-

Operating expense

₹0.25

Net income

₹0.40

Net profit margin

-

Earning per share

₹0.69

EBITDA

₹0.41

Effective tax rate

-

Particulars

Mar 24 (₹ value in crores)

Revenue

-

Operating expense

₹0.19

Net income

-₹0.06

Net profit margin

-

Earning per share

-₹0.10

EBITDA

-₹0.06

Effective tax rate

-

Particulars

Mar 23 (₹ value in crores)

Revenue

-

Operating expense

₹0.22

Net income

-₹0.10

Net profit margin

-

Earning per share

-₹0.17

EBITDA

-₹0.10

Effective tax rate

-

Particulars

Mar 22 (₹ value in crores)

Revenue

-

Operating expense

₹3.92

Net income

-₹3.86

Net profit margin

-

Earning per share

-₹6.55

EBITDA

-₹3.86

Effective tax rate

-

Particulars

Mar 21 (₹ value in crores)

Revenue

-

Operating expense

₹0.31

Net income

-₹0.24

Net profit margin

-

Earning per share

-₹0.41

EBITDA

-₹0.24

Effective tax rate

-

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹18.20

Return on Equity (ROE)

-0.98%

Return on Capital Employed (ROCE)

-1.04%

Total debt to equity ratio

0.01

EBITDA margin

-

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹1.86

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.05

EBITDA margin

-

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹1.68

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.02

EBITDA margin

-

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹1.88

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.08

EBITDA margin

-

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹2.13

Return on Equity (ROE)

-

Return on Capital Employed (ROCE)

-

Total debt to equity ratio

0.13

EBITDA margin

-

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹2.85

Total assets

₹25.60

Total liabilities

₹25.60

Total equity

₹25.43

Shares outstanding

₹1.43

Price to book ratio

₹2.33

Return on assets (%)

1.57%

Return on capital

1.58%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.04

Total assets

₹1.32

Total liabilities

₹1.32

Total equity

₹1.21

Shares outstanding

₹0.58

Price to book ratio

₹7.87

Return on assets (%)

-4.45%

Return on capital

-4.5%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.02

Total assets

₹1.12

Total liabilities

₹1.12

Total equity

₹1.09

Shares outstanding

₹0.58

Price to book ratio

₹3.26

Return on assets (%)

-9.03%

Return on capital

-9.1%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.22

Total assets

₹1.27

Total liabilities

₹1.27

Total equity

₹1.22

Shares outstanding

₹0.58

Price to book ratio

₹3.05

Return on assets (%)

-303.54%

Return on capital

-306.94%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.09

Total assets

₹4.08

Total liabilities

₹4.08

Total equity

₹1.39

Shares outstanding

₹0.58

Price to book ratio

₹1.46

Return on assets (%)

-5.85%

Return on capital

-15.27%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹0.40

Cash from operations

₹0.40

Cash from investing

₹0.33

Cash from financing

₹2.07

Net change in cash

₹2.81

Free cash flow

₹0.40

Particulars

Mar 24 (₹ value in crores)

Net income

-₹0.05

Cash from operations

-

Cash from investing

₹0.07

Cash from financing

-₹0.06

Net change in cash

₹0.01

Free cash flow

-

Particulars

Mar 23 (₹ value in crores)

Net income

-₹0.10

Cash from operations

-₹0.14

Cash from investing

-₹0.11

Cash from financing

₹0.06

Net change in cash

-₹0.20

Free cash flow

-₹0.14

Particulars

Mar 22 (₹ value in crores)

Net income

-₹3.86

Cash from operations

-₹4.00

Cash from investing

₹3.81

Cash from financing

₹0.32

Net change in cash

₹0.13

Free cash flow

-₹4.00

Particulars

Mar 21 (₹ value in crores)

Net income

-₹0.23

Cash from operations

-₹0.39

Cash from investing

₹0.52

Cash from financing

-₹0.07

Net change in cash

₹0.05

Free cash flow

-₹0.39

Bacil Pharma Ltd. technical summary

₹37.03
-2.8 ▼
0
Bearish
16
Bullish
5 Day39.2
10 Day39.8
12 Day40
20 Day40.2
26 Day40.1
50 Day39.6
100 Day39.3
200 Day38.1
5 Day38.7
10 Day39.3
12 Day39.9
20 Day41.1
26 Day41
50 Day39.6
100 Day38.7
200 Day41.6

38.37

PIVOT

First support
₹35.73
First resistance
₹40.73
Second support
₹33.37
Second resistance
₹43.37
Third support
₹30.73
Third resistance
₹45.73
RSI
40.45
ADX
35.89
MACD
-0.34
Williams % R
-90.55
Commodity Channel Index (CCI)
-120.74
Date
06 Feb 2026
Same day
2,095
Week
2,367
Month
3,612
1 year
-0.01
3 years
-0.14
Over 1 month
-12.18%
Over 1 year
-21.12%
Over 3 months
24.93%
Over 3 years
71.89%
Over 6 months
-1.25%
Over 6 years
46.86%

Investment Returns

Over 1 Month12.18%
Over 3 Months24.93%
Over 6 Months1.25%
Over 1 Year21.12%

Bacil Pharma Ltd. Shareholding pattern


Public
99.91%
Promoter holdings
0.08%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Nikita Hiren Patel

27,90,000 (19.44%)

Public Shareholding

Manubhai Amrutlal Shah

26,27,000 (18.3%)

Public Shareholding

Gb Hospitality India Pvt Ltd

20,75,000 (14.46%)

Public Shareholding

Manmohan Jagdishprasad Ghuwalewala

6,00,000 (4.18%)

Public Shareholding

Navin Keshrimal Mehta

3,11,801 (2.17%)

Public Shareholding

Promoter sharesShareCategory
Nikita Hiren Patel27,90,000 (19.44%)Public Shareholding
Manubhai Amrutlal Shah26,27,000 (18.3%)Public Shareholding
Gb Hospitality India Pvt Ltd20,75,000 (14.46%)Public Shareholding
Manmohan Jagdishprasad Ghuwalewala6,00,000 (4.18%)Public Shareholding
Navin Keshrimal Mehta3,11,801 (2.17%)Public Shareholding
Vicky Pratapbhai Shah3,06,695 (2.14%)Public Shareholding
Chhaya Gaurang Shah2,59,799 (1.81%)Public Shareholding
Deepa Navin Mehta2,50,000 (1.74%)Public Shareholding
Saroj Kishor Mehta1,65,861 (1.16%)Public Shareholding
Dhrumil Rakesh Patel1,57,488 (1.1%)Public Shareholding
Gulecha Investment & Trading Co Pvt Ltd10,800 (0.08%)Shareholding of Promoter and Promoter Group
Khem Sum Apparels Overseas Limited200 (0%)Shareholding of Promoter and Promoter Group
Suman P Shah500 (0%)Shareholding of Promoter and Promoter Group

About BACIL PHARMA LTD.

Incorporated as a private limited company in Maharashtra in May '87, Bacil Pharma (BPL) was converted into a public limited company in Oct.'90. The main business activity of the Company is Pharmaceutical. Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus, spread over various States and Districts. It

Parent Organisation

Indian Private

NSE Symbol

BACIL PHARMA LTD.

Founded

1987

BACIL PHARMA LTD. CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)